• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[先天性联合因子V和因子VIII缺乏症一例的去氨加压素给药]

[DDAVP administration in a case of congenital combined factor V and factor VIII deficiency].

作者信息

Takai Y, Hayashi H, Ishimaru F, Fujita T, Tsurumi N, Tsuda T, Kimura I

出版信息

Rinsho Ketsueki. 1989 Nov;30(11):2035-40.

PMID:2607619
Abstract

Combined deficiency of factor V and factor VIII, a rare bleeding disorder, was found in a 43 year-old male. He had often presented manifestations of easy bruising since childhood, but none of his family had shown evidence of a bleeding tendency. We examined him and his family as far as we could and his abnormality of blood coagulation was apparent, but the members of his family were normal. The prothrombin time and activated partial thromboplastin time of this patient were prolonged, but his thrombin time was normal. Factor V and factor VIII coagulant activity were low, but von Willebrand factor antigen and activity (ristocetin cofactor activity) levels were normal. Protein C and Protein C inhibitor antigen and activity levels were also found to be normal. Following 1-deamino-8-D-arginine vasopressin (DDAVP) injection, he had immediate increases in factor VIII coagulant activity, but both von Willebrand factor antigen, activity levels and factor V coagulant activity remained low. Moreover, there was no rapid decline in factor VIII complex activity. These findings suggest that the endogenous factor VIII in this patient is metabolized normally and that at least the deficiency of factor VIII does not result from accelerated degradation in plasma.

摘要

在一名43岁男性中发现了罕见的出血性疾病——凝血因子V和凝血因子VIII联合缺乏症。他自童年起就经常出现容易瘀青的表现,但他的家人均未表现出出血倾向的迹象。我们尽可能对他及其家人进行了检查,他的血液凝固异常明显,但他的家人凝血功能正常。该患者的凝血酶原时间和活化部分凝血活酶时间延长,但凝血酶时间正常。凝血因子V和凝血因子VIII的凝血活性较低,但血管性血友病因子抗原和活性(瑞斯托霉素辅因子活性)水平正常。蛋白C以及蛋白C抑制剂的抗原和活性水平也均正常。注射1-去氨基-8-D-精氨酸加压素(DDAVP)后,他的凝血因子VIII凝血活性立即升高,但血管性血友病因子抗原、活性水平以及凝血因子V凝血活性仍较低。此外,凝血因子VIII复合物活性没有迅速下降。这些发现表明该患者体内的内源性凝血因子VIII代谢正常,并且至少凝血因子VIII的缺乏并非由血浆中加速降解所致。

相似文献

1
[DDAVP administration in a case of congenital combined factor V and factor VIII deficiency].[先天性联合因子V和因子VIII缺乏症一例的去氨加压素给药]
Rinsho Ketsueki. 1989 Nov;30(11):2035-40.
2
[Management of cesarean section under replacement therapy with factor VIII concentrates in a pregnant case with congenital combined deficiency of factor V and factor VIII].
Rinsho Ketsueki. 1991 Sep;32(9):981-5.
3
Response to desmopressin of factors XI, X and V in patients with factor VIII deficiency and von Willebrand disease.VIII因子缺乏症和血管性血友病患者中XI因子、X因子和V因子对去氨加压素的反应。
Br J Haematol. 2004 Jul;126(1):100-4. doi: 10.1111/j.1365-2141.2004.04988.x.
4
Circumcision in a combined factor V and factor VIII deficiency using desmopressin (DDAVP).使用去氨加压素(DDAVP)治疗联合因子V和因子VIII缺乏症时的包皮环切术。
Turk J Pediatr. 2002 Apr-Jun;44(2):146-7.
5
Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.在灰色血小板综合征中,缺乏血小板血管性血友病因子时1-去氨基-8-精氨酸加压素(DDAVP)对出血时间的缩短作用。
Thromb Haemost. 1987 Dec 18;58(4):1060-3.
6
Concentrated DDAVP: further improvement in the management of mild factor VIII deficiencies.去氨加压素浓缩剂:对轻度凝血因子 VIII 缺乏症治疗的进一步改善。
Thromb Haemost. 1987 Oct 28;58(3):896-8.
7
Response of factor VIII/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII).健康受试者和轻度血友病患者(以及对V因子和VIII因子联合缺乏患者的观察)对鼻内去氨加压素的VIII因子/血管性血友病因子反应
Thromb Haemost. 1982 Aug 24;48(1):91-3.
8
[A family of congenital combined deficiency of factor V and von Willebrand factor].
Rinsho Ketsueki. 1990 Mar;31(3):365-70.
9
Combined factor V and factor VIII deficiency with congenital heart disease:response to plasma and DDAVP infusion.联合因子V和因子VIII缺乏合并先天性心脏病:对血浆和去氨加压素输注的反应
Southeast Asian J Trop Med Public Health. 1994 Mar;25(1):217-20.
10
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.静脉注射去氨加压素和因子VIII-血管性血友病因子浓缩物用于治疗和预防1型、2型和3型血管性血友病患者的出血。
Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399.